Balancing cell cycle arrest and immune activation: A synergistic window for idasanutlin and anti-PD-1 therapy in a syngeneic mouse modelAneta Nieznanska, Łukasz Skalniak|Biomedicine & Pharmacotherapy|2025Cited by 1